Christina Shafer - Jun 18, 2024 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC. (MRNS)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Stock symbol
MRNS
Transactions as of
Jun 18, 2024
Transactions value $
$0
Form type
4
Date filed
6/20/2024, 04:22 PM
Previous filing
Feb 22, 2024
Next filing
Aug 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Award $0 +10.9K +18.1% $0.00 71.2K Jun 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNS Stock Option (Right to Buy) Award $0 +49.1K $0.00 49.1K Jun 18, 2024 Common Stock 49.1K $1.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
F2 The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.